The company has not filed an annual or quarterly report since its Q2 FY2024 10-Q, filed Aug 15, 2024. Its latest SEC filing is a 25-NSE from Feb 12, 2025.
10-Q for Q2 FY2024, filed Aug 15, 2024
The sections below describe the company as of the FY2023 annual report.
Seeks to combine with a business through a merger, asset purchase, stock purchase or similar transaction; it had focused its target search on the cannabis industry.
10-K for FY2023, filed Mar 22, 2024
$100K
10-K for FY2023, filed Mar 22, 2024
$100K ↗No. It lost $1M in FY2023.
10-Q for Q2 FY2024, filed Aug 16, 2024
−$350.2KView ↗
8-K, filed Nov 8, 2024
On November 7, 2024, pursuant to Section 8.1(a) of the Merger Agreement, Clover Leaf, CL Merger Sub, Purchaser Representative, Kustom…View ↗
8-K, filed Sep 3, 2024
On August 30, 2024, Clover Leaf Capital Corp., a Delaware corporation (the “Company,” “our” or “we”) received written notice (the “Notice…View ↗
Loading...